Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)
Clinical trial NCT05320159 · COMPLETED
Trial details
- NCT number
- NCT05320159
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-03
- Primary completion
- 2021-03-31
- Enrollment
- 17743
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.